ERBB2 and breast cancer: Here, we found, in ERBB2 gene (EGFR family member, also known as HER2), the c.2329G>T missense mutation caused amino acid substitution (p.Val777Leu) which resulted in excessive activation of downstream signaling pathways in breast cancer, lung cancer, and other tumors (Greulich et al.